bimatoprost 0.01 MG Drug Implant
- RxCUI
- 2286602
- RxNorm name
- bimatoprost 0.01 MG Drug Implant
- Display name
- bimatoprost 0.01 MG Drug Implant
- Full name
- bimatoprost 0.01 MG Drug Implant
- Term type
- SCD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:55
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| DURYSTA | BIMATOPROST | Allergan, Inc. | 3f59da84-0bcc-4c84-b3e2-e215681ef341 | 2024-10-16 | Warnings, Adverse reactions | 2286602 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 3f59da84-0bcc-4c84-b3e2-e215681ef341 | bimatoprost 0.01 MG Drug Implant | SCD | 15 | These highlights do not include all the information needed to use DURYSTA safely and effectively. See full prescribing information for DURYSTA. DURYSTA ® ( bimatoprost intracameral implant), for intracameral administration Initial U.S. Approval: 2001 | 20241016 |
| 3f59da84-0bcc-4c84-b3e2-e215681ef341 | bimatoprost 10 MCG Drug Implant | SY | 15 | These highlights do not include all the information needed to use DURYSTA safely and effectively. See full prescribing information for DURYSTA. DURYSTA ® ( bimatoprost intracameral implant), for intracameral administration Initial U.S. Approval: 2001 | 20241016 |
| 3f59da84-0bcc-4c84-b3e2-e215681ef341 | bimatoprost 10 MCG Intracameral Implant | PSN | 15 | These highlights do not include all the information needed to use DURYSTA safely and effectively. See full prescribing information for DURYSTA. DURYSTA ® ( bimatoprost intracameral implant), for intracameral administration Initial U.S. Approval: 2001 | 20241016 |